基于接触力感知的射频导管消融治疗阵发性室上性心动过速(COBRA-PATH):一项随机对照试验
COBRA-PATH 为单中心双臂随机对照试验,纳入无结构性心脏病、因阵发性室上性心动过速(PSVT)拟行电生理检查并可能接受射频消融的患者,比较标准非灌注射频导管与带接触力感知的开放灌注导管(虚拟非灌注模式)手动消融。主要终点为房室结折返性心动过速消融及沃夫-帕金森-怀特综合征与房室折返性心动过速消融中射频应用次数差异,次要终点包括急性和长期手术成功率、射频总时长、手术/透视时长及安全性。
要点
- 接触力感知技术在心房颤动消融中已显示改善预后,但在PSVT消融中尚未应用。
- 研究假设接触力感知可减少达到有效损伤所需的射频应用次数和时长,进而缩短手术和透视时间。
- 鉴于标准消融成功率已较高,研究可能难以证明成功率显著提升,但缩短手术时长和减少辐射暴露具有临床意义。
核心结论
- 接触力感知技术能否进一步改善PSVT消融结局尚待COBRA-PATH试验验证。
研究设计与样本
- COBRA-PATH为单中心、双臂随机对照试验,纳入无结构性心脏病、因PSVT拟行电生理检查并可能接受射频消融的患者。
- 患者随机分配至标准非灌注射频导管手动消融组或带接触力感知的开放灌注导管(虚拟非灌注模式)手动消融组。
关键数值与推荐
- 主要终点为房室结折返性心动过速消融及沃夫-帕金森-怀特综合征与房室折返性心动过速消融中射频应用次数的差异。
- 次要终点包括急性和长期手术成功率、射频应用总时长、手术/透视时长及安全性参数。
临床怎么用
- 若接触力感知可减少射频应用次数和时长,可能缩短PSVT消融手术和透视时间,降低辐射暴露。
局限性
- 鉴于标准消融方法成功率已较高,研究可能难以证明急性和长期手术成功率的显著改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple studies have demonstrated the importance of adequate catheter-tissue contact in the creation of effective lesions during radiofrequency catheter ablation. The development of contact force (CF)-sensing catheters has contributed significantly to improve clinical outcomes in atrial fibrillation. However, CF-sensing technology is not used in the ablation of paroxysmal supraventricular tachycardia (PSVT). The possible reason for this is that PSVT ablation with the conventional approach (i.e. nonirrigated, non-CF-sensing catheters) is considered a relatively low-risk procedure with fairly high success rates (short and long term). The aim of this study is to determine whether CF sensing can further improve the outcomes of PSVT ablation. METHODS/DESIGN: The COBRA-PATH study is a single-center, two-armed, randomized controlled trial. Patients without structural heart disease being referred for electrophysiology study, because of PSVT and potential treatment with radiofrequency (RF) catheter ablation, will be randomly assigned to either manual ablation with standard nonirrigated ablation catheters or manual ablation with an open-irrigated ablation catheter equipped with CF sensing (used in a virtual nonirrigated modus). The primary study endpoint is the difference in the number of RF applications during the ablation of atrioventricular nodal re-entry tachycardia, and that of Wolff-Parkinson-White syndrome and atrioventricular re-entrant tachycardia. Secondary outcome parameters include acute and long-term procedural success rates, overall duration of RF applications, procedure/fluoroscopy durations and safety parameters. DISCUSSION: We expect to see a reduced number/duration of RF applications required to achieve effective lesion creation, and consequently a decrease in total procedure/fluoroscopy times. Although a significant improvement in procedural success rates (acute/long term) might not be feasible to demonstrate (given the relatively high success rate of the standard ablation method), the possible decrease in procedure duration and the consequential reduction of radiation exposure has important clinical implications for both operators and patients undergoing the procedure. TRIAL REGISTRATION: ClinicalTrials, NCT04078685. Retrospectively registered on 2 September 2019.
引用
- Geczy T, Ramdat Misier NL, Szili-Torok T, et al. Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias (COBRA-PATH): a randomized controlled trial. Trials. 2020. PMID: 32272969. doi:10.1186/s13063-020-4219-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。